These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
4. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ; Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227 [TBL] [Abstract][Full Text] [Related]
5. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ; Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961 [TBL] [Abstract][Full Text] [Related]
7. How Great a Risk Do You Take? A Qualitative Study Exploring Attitudes of Individuals with Friedreich Ataxia Toward Gene Therapy. Lieschke K; Scott V; Delatycki MB; Lewis S; Munsie M; Tanner C; Corben LA Hum Gene Ther; 2023 Oct; 34(19-20):1041-1048. PubMed ID: 37624740 [TBL] [Abstract][Full Text] [Related]
8. Sexual function, intimate relationships and Friedreich ataxia. Corben LA; Hermans MM; Marks A; Crowe LM; Delatycki MB J Neurol; 2021 Mar; 268(3):1088-1095. PubMed ID: 33047222 [TBL] [Abstract][Full Text] [Related]
9. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ; Clin Endocrinol (Oxf); 2018 Sep; 89(3):251-268. PubMed ID: 30024653 [TBL] [Abstract][Full Text] [Related]
10. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Costello MF; Misso ML; Balen A; Boyle J; Devoto L; Garad RM; Hart R; Johnson L; Jordan C; Legro RS; Norman RJ; Mocanu E; Qiao J; Rodgers RJ; Rombauts L; Tassone EC; Thangaratinam S; Vanky E; Teede HJ; Hum Reprod Open; 2019; 2019(1):hoy021. PubMed ID: 31486807 [TBL] [Abstract][Full Text] [Related]
11. Critical Care Network in the State of Qatar. Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205 [TBL] [Abstract][Full Text] [Related]
12. Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations. Lynch DR; Perlman S; Schadt K Expert Rev Neurother; 2024 Mar; 24(3):251-258. PubMed ID: 38269532 [TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of the Friedreich Ataxia Impact Scale. Tai G; Yiu EM; Corben LA; Delatycki MB J Neurol Sci; 2015 May; 352(1-2):53-7. PubMed ID: 25840637 [TBL] [Abstract][Full Text] [Related]
14. Common data elements for clinical research in Friedreich's ataxia. Lynch DR; Pandolfo M; Schulz JB; Perlman S; Delatycki MB; Payne RM; Shaddy R; Fischbeck KH; Farmer J; Kantor P; Raman SV; Hunegs L; Odenkirchen J; Miller K; Kaufmann P Mov Disord; 2013 Feb; 28(2):190-5. PubMed ID: 23239403 [TBL] [Abstract][Full Text] [Related]
15. Society of Critical Care Medicine Clinical Practice Guidelines for Rapid Sequence Intubation in the Critically Ill Adult Patient. Acquisto NM; Mosier JM; Bittner EA; Patanwala AE; Hirsch KG; Hargwood P; Oropello JM; Bodkin RP; Groth CM; Kaucher KA; Slampak-Cindric AA; Manno EM; Mayer SA; Peterson LN; Fulmer J; Galton C; Bleck TP; Chase K; Heffner AC; Gunnerson KJ; Boling B; Murray MJ Crit Care Med; 2023 Oct; 51(10):1411-1430. PubMed ID: 37707379 [TBL] [Abstract][Full Text] [Related]
17. Guidelines on the diagnosis and management of the progressive ataxias. de Silva R; Greenfield J; Cook A; Bonney H; Vallortigara J; Hunt B; Giunti P Orphanet J Rare Dis; 2019 Feb; 14(1):51. PubMed ID: 30786918 [TBL] [Abstract][Full Text] [Related]
18. Strategies for eliciting and synthesizing evidence for guidelines in rare diseases. Pai M; Yeung CHT; Akl EA; Darzi A; Hillis C; Legault K; Meerpohl JJ; Santesso N; Taruscio D; Verhovsek M; Schünemann HJ; Iorio A BMC Med Res Methodol; 2019 Mar; 19(1):67. PubMed ID: 30922227 [TBL] [Abstract][Full Text] [Related]
19. Clinical Practice Guideline: Sudden Hearing Loss (Update). Chandrasekhar SS; Tsai Do BS; Schwartz SR; Bontempo LJ; Faucett EA; Finestone SA; Hollingsworth DB; Kelley DM; Kmucha ST; Moonis G; Poling GL; Roberts JK; Stachler RJ; Zeitler DM; Corrigan MD; Nnacheta LC; Satterfield L Otolaryngol Head Neck Surg; 2019 Aug; 161(1_suppl):S1-S45. PubMed ID: 31369359 [TBL] [Abstract][Full Text] [Related]
20. Natural History of Friedreich Ataxia: Heterogeneity of Neurologic Progression and Consequences for Clinical Trial Design. Rummey C; Corben LA; Delatycki M; Wilmot G; Subramony SH; Corti M; Bushara K; Duquette A; Gomez C; Hoyle JC; Roxburgh R; Seeberger L; Yoon G; Mathews K; Zesiewicz T; Perlman S; Lynch DR Neurology; 2022 Oct; 99(14):e1499-e1510. PubMed ID: 35817567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]